- Home
- ELTK vs EPIX Comparison
ELTK vs EPIX Comparison
Compare ELTK & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- EPIX
- Stock Information
- Founded
- ELTK 1970
- EPIX 2009
- Country
- ELTK Israel
- EPIX Canada
- Employees
- ELTK N/A
- EPIX N/A
- Industry
- ELTK Electrical Products
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- EPIX Health Care
- Exchange
- ELTK Nasdaq
- EPIX Nasdaq
- Market Cap
- ELTK 66.7M
- EPIX 65.3M
- IPO Year
- ELTK 1997
- EPIX N/A
- Fundamental
- Price
- ELTK $10.15
- EPIX $1.68
- Analyst Decision
- ELTK
- EPIX Hold
- Analyst Count
- ELTK 0
- EPIX 3
- Target Price
- ELTK N/A
- EPIX $2.00
- AVG Volume (30 Days)
- ELTK 23.1K
- EPIX 138.8K
- Earning Date
- ELTK 05-20-2025
- EPIX 05-08-2025
- Dividend Yield
- ELTK 1.85%
- EPIX N/A
- EPS Growth
- ELTK N/A
- EPIX N/A
- EPS
- ELTK 0.51
- EPIX N/A
- Revenue
- ELTK $47,500,000.00
- EPIX N/A
- Revenue This Year
- ELTK $18.60
- EPIX N/A
- Revenue Next Year
- ELTK $9.04
- EPIX N/A
- P/E Ratio
- ELTK $19.72
- EPIX N/A
- Revenue Growth
- ELTK 1.05
- EPIX N/A
- 52 Week Low
- ELTK $7.65
- EPIX $1.40
- 52 Week High
- ELTK $12.29
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- ELTK 56.33
- EPIX 49.37
- Support Level
- ELTK $9.90
- EPIX $1.60
- Resistance Level
- ELTK $10.50
- EPIX $1.70
- Average True Range (ATR)
- ELTK 0.49
- EPIX 0.05
- MACD
- ELTK -0.06
- EPIX -0.01
- Stochastic Oscillator
- ELTK 31.37
- EPIX 53.33
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.